What You Should Know:
- Thyme Care, a value-based cancer care enabler secures $97M in Series D funding, bringing its total capital raised to $275M.
The funding round was overwhelmingly backed by strategic investors, including current investors such as CVS Health® Ventures, Foresite Capital, and a16z Bio + Health, with new strategic investors including Morgan Health (JPMorganChase), Humana, Texas Oncology, and Memorial Hermann Health System.
- The company also achieved
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics for Cancer
What You Should Know:
- Lunit, a provider of AI for cancer diagnostics, and Agilent Technologies Inc., a global leader in life sciences, have announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions.
- The strategic partnership will combine Lunit's AI technology with Agilent’s expertise in tissue-based companion diagnostics. The goal is to create advanced solutions that meet the demands of novel and complex biomarker assays in drug
Read More
Flatiron Health Triples Global Oncology Research Network
What You Should Know:
- Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced that its international oncology research network has tripled in size across the UK, Germany, and Japan over the past year—a milestone that marks an unprecedented acceleration in global cancer research collaboration and impact.
- Flatiron Health entered international markets to address the growing unmet need for
Read More
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
What You Should Know:
- Lunit, a provider of AI for cancer diagnostics and therapeutics announced a strategic collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions globally.
- The partnership, coupled with Lunit’s recent acquisition of Volpara (a Microsoft Industry Health Certified Partner), aims to provide health professionals worldwide with advanced tools for cancer detection.
Driving Scalable, Integrated AI in Healthcare
The strategic
Read More
Artera Launches Real-World Registry to Track AI’s Impact in Cancer Care
What You Should Know:
- Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
- The study will also monitor participants to evaluate their long-term cancer outcomes, reinforcing Artera's commitment to advancing
Read More
Cleveland Clinic & Amwell Expand Virtual Cancer Concierge Program Nationwide
What You Should Know:
- The Clinic by Cleveland Clinic, a leading provider of virtual second opinions (VSOs), announced the expansion of Cancer Concierge by Cleveland Clinic—a program connecting cancer patients across the U.S. with expert oncology subspecialists.
- The program, offered by The Clinic and its partner Amwell, expands on traditional VSOs by offering advanced subspecialty reviews, insight into innovative treatments and trials, cancer education content, and optional follow-up
Read More
85% of Cancer Patients Face Unnecessary Insurance “Red Tape” Due to Prior Authorization, Says New CancerCare Report
What You Should Know:
- A new national survey from CancerCare reveals how insurance utilization management practices, particularly prior authorization, create serious and stressful barriers to care for cancer patients. The report, titled "The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management," found that these requirements frequently delay diagnosis and treatment, adding significant "time toxicity" to patients' lives.
- The
Read More
Full-Body MRI Detects Cancers Missed by Standard Screenings
What You Should Know:
- Prenuvo, a leader in whole-body MRI for proactive health screening, today announced compelling results from its Polaris study. The real-world study of over 1,000 asymptomatic individuals found that whole-body MRI scans can detect critical conditions, including early-stage cancers, that are often missed by current standard screening guidelines.
- The findings have been peer-reviewed and accepted for presentation at the American Association for Cancer
Read More
ASCO and Google Cloud Launch AI-Powered Guidelines Assistant to Transform Oncology Decision-Making
What You Should Know:
- The American Society of Clinical Oncology (ASCO) and Google Cloud today announced a collaboration to launch an AI-based ASCO Guidelines Assistant.
- Developed using Google Cloud's Vertex AI platform and advanced Gemini models, this innovative tool is set to revolutionize how oncology professionals access and utilize critical clinical recommendations.
AI-Powered Access to Trusted Clinical Recommendations
A cornerstone of the ASCO Guidelines
Read More
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care
What You Should Know:
- McKesson has unveiled the Precision Care Companion (PCC), a transformative initiative designed to tackle the multifaceted challenges that healthcare practices face in the rapidly evolving landscape of genomic testing and targeted therapies.
- The Precision Care Companion is structured as a consortium of leading industry experts, spearheaded by McKesson. This collaborative model is intentionally designed to foster a dynamic environment that unites a diverse
Read More
